Roivant Sciences Ltd. (ROIV) — Analyst outlook / Analyst consensus target is. Based on 14 analyst ratings, the consensus is bullish — 13 Buy, 1 Hold.
The consensus price target is $31.50 (low: $30.00, high: $34.00), representing an upside of 8.2% from the current price $29.12.
Analysts estimate Earnings Per Share (EPS) of $6.09 and revenue of $0.16B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.24 vs est $6.09 (missed -103.9%). Analyst accuracy: 0%.
ROIV Stock — 12-Month Price Forecast
$31.50
▲ +8.17% Upside
Average Price Target
Based on 14 Wall Street analysts offering 12-month price targets for Roivant Sciences Ltd., the average price target is $31.50, with a high forecast of $34.00, and a low forecast of $30.00.
The average price target represents a +8.17% change from the last price of $29.12.
Highest Price Target
$34.00
Average Price Target
$31.50
Lowest Price Target
$30.00
ROIV Analyst Ratings
Buy
Based on 14 analysts giving stock ratings to Roivant Sciences Ltd. in the past 3 months
EPS Estimates — ROIV
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$0.24
vs Est $6.09
▼ 2,669.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.
Revenue Estimates — ROIV
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $0.029B
vs Est $0.158B
▼ 444.9% off
Revenue Trend
Analysts forecast significant revenue growth ahead.
